- 12 oral surgery updates in 2026
- 5 ASC, MOB deals in California
- Hidden OR capacity challenges: 8 perioperative leaders on what’s draining surgical time
- The Aspen Group’s 3-year growth recap: 40 moves
- Florida State University set to acquire Tallahassee hospital
- How Confusing Financial Journeys Undermine Revenue and Trust
- How Confusing Financial Journeys Undermine Revenue and Trust
- Misalignment, Not Malice: Rethinking Generational Conflict in Healthcare
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 8 Medicare Advantage numbers to know in 2026
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
The Senate bill hasn't yet been written, but Senate Leader Chuck Schumer promises a vote on Obamacare premium support subsidies next week. The C-SPAN coverage of the debate in the "Cave Of The Winds" should be Must-See TV:
Health subsidies would continue for 3 years under Dem bill to be voted on in US Senate
By Jennifer Shutt - December 4, 2025WASHINGTON — U.S. Senate Democratic Leader Chuck Schumer announced Thursday the chamber will vote next week to extend enhanced tax credits for three years for people who purchase their health insurance from the Affordable Care Act marketplace, though the plan seems unlikely to get the bipartisan support needed to advance.
While it would typically be difficult for the minority leader to schedule a floor vote, Senate Majority Leader John Thune, R-S.D., agreed that Democrats could bring up a health care bill of their choosing in exchange for voting to end the government shutdown.
Schumer told reporters in recent days to “stay tuned” for details about the legislation while maintaining all Senate Democrats were united around the proposal. The three-year plan he previewed during his floor speech appears identical to one House Democratic leaders have been pressing for in that chamber.
“Any Republican who claims to care about premium increases on January 1 has only one realistic path, and that’s to support our bill for a simple, clean, three-year extension,” Schumer said. “If Republicans block our bill, there’s no going back. We won’t get another chance to halt these premium spikes before they kick in at the start of the new year.”
The vote will take place next Thursday, Schumer said.
Clock ticking on solution
Health care costs have surged to the forefront of the national conversation in recent months, with both Democrats and Republicans in Congress pledging to find solutions. Both agree much more time is needed to make larger, structural changes.
The Senate committee in charge of health care policy held a hearing Wednesday where senators began to coalesce around extending the enhanced tax credits beyond the end-of-December sunset date. But a bipartisan bill has not yet been introduced in that chamber on that subject.
Health, Education, Labor and Pensions Chairman Bill Cassidy, R-La., said just after the hearing wrapped up there will likely be a GOP bill, or even a bipartisan one, to counter Schumer’s bill.
“Yeah, absolutely,” Cassidy said. “I’d like to have a plan that both sides can vote for. But there will be a Republican plan if I have anything to do with it.”
Congress has an especially brief time frame to find a short-term resolution on the expiring tax credits, which would lead the cost of ACA marketplace plans to rise by hundreds or thousands of dollars.
Open enrollment for ACA marketplace plans ends at different times throughout the country, with some states finishing on Dec. 15. Residents of other states are able to sign up through varying dates in January, but with their coverage starting later in the year. Lawmakers are set to leave Capitol Hill on Dec. 19 for their winter holiday break.
A poll released Thursday by the nonpartisan health organization KFF showed nearly 60% of ACA marketplace enrollees could not cover the costs of a $300 annual increase in their premiums, while an additional 20% said they couldn’t afford a $1,000 jump in prices per year.
Gottheimer, Kiggans unveil House bipartisan bill
At the same time Schumer was speaking on the Senate floor, a bipartisan group of House lawmakers, led by New Jersey Democratic Rep. Josh Gottheimer and Virginia Republican Rep. Jen Kiggans, introduced a bill they said could address some of the short-term issues facing ACA enrollees.
“Although we may have different opinions over the long-term solutions for reforming marketplace health care or if there are even better and cheaper options for publicly available health insurance, we agree on the many aspects of the short-term solutions,” Kiggans said.
The legislation — which needs to pass a floor vote, make it through the Senate and garner President Donald Trump’s signature — would extend the enhanced ACA marketplace tax credits with new income caps, “guardrails for waste, fraud and abuse” and an overhaul of the pharmacy benefit manager, or PBM, system, Kiggans said.
The bipartisan group of representatives would then move on to the second part of their plan, not included in the bill, where they would try to make more structural changes to the entire country’s health care system.
Those bills, Kiggans said, would address hospital billing transparency, implement Health Savings Accounts and advance the Give Kids a Chance Act “to accelerate pediatric cancer treatments and expand access to life-saving therapies for children battling rare diseases.”
Gottheimer said the group wants House leaders to put their bill up for a vote before members leave town for the two-week, end-of-year break.
“In the last month, families have seen their health insurance premiums surge as they’ve shopped for insurance during open enrollment because enhanced premium tax credits are set to expire, as we all know, at the end of the year,” Gottheimer said. “In fact, because of this, for millions of families on the ACA, their health premiums will rise an average of 26% next year.
“In Jersey, where we live, it could be even rougher with a 175% increase. That’s $20,000 for a family of four. And that’s why we’re all here together to try to solve this problem, do something about it, and avoid a massive new tax on hard-working families,” he said.
Senators don’t see future in bipartisan House bill
Schumer and other Senate Democrats didn’t appear to take the bipartisan House plan seriously when pressed about it during an early afternoon press conference, asking reporters in the room whether Speaker Mike Johnson, R-La., would actually put it on the floor for a vote.
“As for whatever House proposals there are, we’ll always look at something, but I don’t even see 15 Republicans supporting it right now,” Schumer said. “Sure an individual or two or three people can say this or that. It’s not going to solve the problem.”
Schumer maintained Senate Democrats’ three-year extension, which does not come with income caps or other changes to the tax credits proposed by centrist Republicans, is the best path forward.
He appeared frustrated when reporters asked him why he didn’t include changes that could have swayed at least some GOP senators to vote for the bill.
Schumer said it wasn’t worth it for Democrats to put together a bill that a few Republicans might support when he doesn’t expect Speaker Johnson to put the bill on the floor in that chamber given strong opposition to the enhanced tax credits by “half his caucus.”
“Come on,” he said. “The fault is there, not with us.”
The Hill's beginning of the week assessment:
https://thehill.com/policy/healthcare/5636382-health-care-obamacare-house-senate/
Health care fight hits critical juncture
By Mike Lillis and Emily Brooks - December 7, 2025The fierce fight over health care costs hits a crucial juncture this week, with a series of major developments that could make or break the future of enhanced ObamaCare subsidies.
For months, GOP leaders have been squeezed between centrist Republicans clamoring to extend the Affordable Care Act (ACA) tax credits, which expire at year’s end, and more conservative lawmakers fighting to see them lapse. Democrats, from the sidelines, have fueled the clash by demanding a “clean” extension to prevent premiums from skyrocketing for millions of Americans in January.
Those fights all come to a head this week, when Speaker Mike Johnson (R-La.) is expected to introduce a leadership-endorsed health care plan; the Senate is set to vote on the Democrats’ three-year extension; and Rep. Brian Fitzpatrick (R-Pa.) is vowing to introduce yet another bipartisan blueprint he says has the best shot of actually becoming law.
“We’re just trying to thread a needle to get to 218 and 60 [votes], that’s it,” Fitzpatrick said. “I think it’s the most serious attempt out there.”
This week’s Senate vote is the result of a deal that ended the historic 43-day government shutdown. But while Senate Majority Leader John Thune (R-S.D.) promised a vote on extending the subsidies, there was no guarantee of Republican support. The plan Senate Minority Leader Chuck Schumer (D-N.Y.) will bring up aims to extend the premium subsidies for three years, but it is expected to fail.
Various groups of Republican and Democratic moderates, meanwhile, have put forward their own proposals to extend the subsidies while implementing reforms like income caps and an elimination of plans without premiums.
Republican division on how to approach the subsidy expiration deadline is only increasing the anxiety those in the party are feeling about communicating an affordability message as they enter a midterm election year when control of the House is very much in play.
Swing-seat Republicans at risk of losing their seats are the loudest voices in favor of extending the subsidies in some form, so constituents aren’t faced with hefty premium increases caused in part by the subsidy expiration.
“A lot of my friends, a lot of people I know, won their elections by 1 or 2 [points]. So do I think that if you won your election by 2 points that it matters? Absolutely. It makes a big difference,” said Rep. Jeff Van Drew (R-N.J.).
“It’s not just political buzzwords,” he continued. “I’ve talked to die-hard, ruby-red Republicans that are really concerned and upset about this. This is a huge increase in costs.”
But a large number of conservatives in the party, who have long railed against ObamaCare and balked at the subsidy enhancements when Democrats enacted them during the COVID-19 pandemic, staunchly oppose any extension out of principle.
Plus, many anti-abortion Republicans will refuse to vote for any plan that fails to impose explicit prohibitions on ACA health plans that cover abortions. None of the proposals being floated by centrist Republicans include such language.
One House Republican who spoke to The Hill said that there is broad recognition in the conference that a bipartisan deal to extend the health care subsidies is exceedingly unlikely because of those dynamics and wondered why GOP leaders have not yet ruled out that possibility.
GOP leaders have been hinting that the health care plan they are expected to unveil this week will consist of alternative health care affordability proposals beyond the subsidies. Republicans for weeks have been discussing ideas like expanding access to health savings accounts — all while reviving longtime attacks on ObamaCare as a failed, expensive program.
House Majority Leader Steve Scalise (R-La.) said last week that there is “nothing affordable about the Affordable Care Act.”
“We’re going to keep bringing bills to the floor to do those two things, to lower premiums for families and give them options so that they can get what’s best for their families,” Scalise said. “They don’t have to be forced into a plan that the government tells them they have to be in that’s too expensive for them. It doesn’t work for their family, they can buy whatever they want that makes sense for them and for their family.”
But any legislation that features a conservative health policy wish list, without extending the ObamaCare subsidies, has little chance of passing through the Senate, where Democratic support is vital to securing the 60 votes needed to defeat a filibuster. Faced with that mathematical reality, some centrist Republicans are urging GOP leaders not to pursue a partisan messaging bill that has no chance of becoming law.
“Having accounts — spending accounts and having health savings accounts — that’s a good idea, and maybe we should even do that,” said Van Drew. “But it’s not going to do it in itself right now.”
Fitzpatrick, a co-chair of the bipartisan Problem Solvers Caucus, was even more blunt.
“If it’s not a two-party solution, it’s not a serious attempt to fix the problem,” he said. “What good does it do to put a Republican-only bill on the floor that’s not [going to become law]?”
Asked if a vote must happen by the end of the year, Fitzpatrick didn’t hesitate: “100 percent,” he said.
And as a last-gasp strategy, Fitzpatrick is vowing to pursue a discharge petition to force such a vote if GOP leaders refuse to stage it themselves. That process is typically time-consuming, but he says there are several “shells” available that have already “ripened” according to House rules, allowing supporters of an ACA subsidy extension to move legislation to the floor before year’s end.
“We’ve received no commitments [from leadership],” he said. “But we have commitments to each other that we’re going to get a bill to the floor.”
The U.S. House will not extend PPACA premium support subsidies. AG Dana Nessel will be disappointed to learn that the Freedom Caucus is demanding expansion of the Hyde Amendment:
https://thehill.com/homenews/house/5642438-house-gop-health-care-vote-subsidies/
House GOP health care package will exclude ACA subsidy extension
By Emily Brooks and Nathaniel Weixel - December 10, 2025House GOP leaders will bring a vote next week on a package of health care bills that does not include an extension of expiring ObamaCare enhanced subsidies, as Republicans remain divided about how to address the health care cliff ahead of a midterm election year.
Speaker Mike Johnson (R-La.) told reporters the legislation will comprise GOP-backed ideas that “every Republican agrees to,” which have been discussed across various House committees this year.
“We have some low-hanging fruit that every Republican agrees to,” Johnson said at a press conference. “You’re going to see a package come together that will be on the floor next week that will actually reduce premiums for 100 percent of Americans who are on health insurance.”
But that package is not set to include any measure to extend the subsidies that expire at the end of the year. If those enhanced subsidies expire, out-of-pocket costs for health insurance will spike drastically for millions of Americans.
Following a House GOP conference meeting Wednesday morning, House Majority Leader Steve Scalise (R-La.) said there was no consensus about extending the expiring enhanced subsidies.
“There wasn’t agreement,” Scalise said. “We’ve got to bring items right now that we have full consensus on, because we have such a small majority, and we’ll be doing that.”
Leaders did not articulate which specific provisions they will bring up but mentioned a number of proposals they presented to members in a Wednesday morning conference meeting.
The proposals, they argued, would lower health care premiums for Americans across the board, and not just the 22 million Americans who receive those enhanced subsidies — which leaders framed as just 7 percent of Americans.
Those proposals included expansion of health savings accounts, association health care plans, reforms to the pharmacy benefit manager industry and price transparency.
Some of those ideas had bipartisan support in the past, but a bill that doesn’t address the expiring subsidies is unlikely to get 60 votes to pass the Senate.
The Senate, meanwhile, is set to vote Thursday on competing Republican and Democratic health care plans — one to extend the subsidies, the other to turn the subsidies into federally funded health savings accounts for people on high-deductible plans. Neither proposal is expected to pass.
Moderate members and Republicans in competitive districts pushed in the meeting for their various proposals to extend the subsidies in some form.
Rep. Kevin Kiley (R-Calif.) said he presented his bipartisan plan that would extend the subsidies for two years with some other reforms.
“The Speaker heard it, so I hope he acts accordingly,” Kiley said, adding that despite numerous bipartisan proposals in the House for a temporary subsidy extension, there was no commitment from leadership to support any of them.
“The immediate question is on this cliff, with the expiration of the subsidies, which will lead to 22 million people having to pay a lot more for health insurance. … So I think that’s the priority. We need to actually pass something that will become law that will stop that health care cliff.”
But there was fierce pushback to those moderates in the meeting from members who said the COVID-era enhancements enacted by Democrats were too costly, among other issues — such as demands that any subsidy extension include an expansion of Hyde Amendment prohibitions on abortion coverage in Affordable Care Act plans.
“I would never consider any form of subsidy extension without Hyde protections,” said Rep. Andy Harris (R-Md.), chair of the House Freedom Caucus.
Rep. Gregory Murphy (R-N.C.) in the meeting urged his colleagues against signing any discharge petition to circumvent House leadership and force a vote on a proposal to extend the subsidies, according to one member.
Rep. Brian Fitzpatrick (R-Pa.), the most recent lawmaker to put forward such a plan, is eyeing a discharge petition to force a vote on his two-year subsidy extension and reform bill; and House Minority Leader Hakeem Jeffries (D-N.Y.) is hoping moderate Republicans sign on to his discharge petition to extend the subsidies as-is for three years.
PPACA premium support subsidies are not going to happen. All Senate votes failed and the Congress goes into recess next week:
Obamacare health subsidy to end as US Senate rejects dueling remedies
By Nolan D. McCaskill and Richard Cowan - December 11, 2025Summary
- Senate rejects Republican and Democratic healthcare proposals
- Democratic plan sought subsidy extension; Republicans offered to boost health savings accounts
- Majority of Americans support extending healthcare subsidies, poll shows
WASHINGTON, Dec 11 (Reuters) - The U.S. Senate on Thursday rejected competing proposals by Republicans and Democrats to address a looming healthcare crisis, leaving some 24 million Americans vulnerable to significantly higher insurance premiums beginning on January 1 when a federal subsidy expires.
Barring any late breakthroughs, Congress will begin an end-of-year holiday recess sometime next week and not return until January 5, after new premiums are locked in for those who had relied on the Affordable Care Act enhanced subsidy.
In back-to-back votes largely along party lines, Democrats and Republicans blocked each other's bill.
The House of Representatives might attempt to pass some sort of legislation next week, which has not yet been unveiled. Even if it were to pass, Senate Democrats, and possibly some Republicans, would oppose it and they could use their votes to kill that effort.
"After today's vote, the American healthcare crisis is 100% on their shoulders," Senate Democratic leader Chuck Schumer said of Republicans.
Senate Republican leader John Thune dismissed the Democratic bill as "a political messaging exercise" and said "Republicans are ready to get to work. I'm not sure yet that Democrats are interested."
The bitter battle in Congress has left some Americans uncertain over renewing their health insurance under the federal healthcare program.
The percentage of returning customers in the Obamacare exchanges is slightly down from a year ago, with the government reporting 19.9% of people enrolled this year opting to renew their plans so far, down from 20.5% this time last year.
The Republican bill by U.S. Senators Bill Cassidy of Louisiana and Mike Crapo of Idaho would have sent up to $1,500 to individuals earning less than 700% of the federal poverty level — about $110,000 for an individual or $225,000 for a family of four in 2025. Those funds could not be used for abortion or gender transition procedures and would require verification of beneficiaries' immigration or citizenship status — provisions Democrats reject.
The Democratic proposal on the subsidies under the Affordable Care Act, popularly known as Obamacare, would have extended COVID-era subsidies for three years to keep insurance premiums from soaring for many. Without action by Congress, those premiums could more than double in cost on average, according to KFF, a health policy organization.
Sixty votes were needed to pass either measure in a Senate that Republicans control 53-47. Four Republicans voted for the Democratic proposal. No Democrats backed the Republicans' bill.
President Donald Trump has largely sat out the brawl over healthcare, although he ultimately embraced the Cassidy-Crapo approach.
The $1,500 payments in the Republican bill were meant to cover some of the out-of-pocket costs that people in the "Bronze" or "Catastrophic" categories - the lower-cost Obamacare plans - need to pay before their insurance kicks in.However, it is far below the plans’ deductibles, meaning that even after that payment, a patient would be on the hook for up to $7,500 in out-of-pocket medical expenses before their insurance would start to pay for part of their care.
Those costs can rack up quickly for people with lower-cost plans, with a visit to a U.S. emergency room costing between $1,000 and $3,000, while an ambulance ride can cost anywhere from $500 to over $3,500.
MIDTERM ELECTIONS LOOM
With 2026 congressional elections coming into focus, many Republicans are nervous about the prospect of stiff premium increases hitting every state, including many that backed Trump's 2024 re-election. Polling indicates voters could mostly punish Republicans, who control Congress and the White House.
Republican U.S. Senator Josh Hawley of Missouri, a state that Trump carried by 18 points in his 2024 re-election, said his constituents have been telling him, "We can't afford our premiums now, let alone if they would go up by 50 or 100%."
Insurance companies warned customers of the rising premiums in the new year, and Democrats argued there was not enough time to do anything but a clean extension of the tax credits they sought.
A new Reuters/Ipsos poll found Americans back a healthcare subsidy continuation. Some 51% of respondents — including three-quarters of Democrats and a third of Republicans — said they support extending the subsidies. Only 21% said they were opposed.
Moderate Republican Representative Brian Fitzpatrick of Pennsylvania is spearheading a bipartisan bill to extend the subsidy through 2027. He is hoping to garner enough support to circumvent leadership and force votes on the measure by the full House.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















